Corporate Eye

 
Corporate Eye
  Mon to Fri @ 11 AM  

Going beyond the headline to connect directly with the companies that are the buzzing stock movers on Dalal Street.


ICICI Pru Q4 PAT at Rs 340 Cr

ICICI Pru Q4 PAT at Rs 340 Cr

5 hrs ago | 5 hrs ago

ICICI Prudential posted its Q4FY18 with net profit down 16.6% at Rs 340Cr Vs Rs 408Cr on YoY basis. To decode and discuss the quarter gone by in detail, we caught up with Santosh Singh of Haitong Securities.

12 IPOs to hit D-Street in 2 months

12 IPOs to hit D-Street in 2 months

Apr 24 2018

The IPO pipeline is about to buzz with a dozen IPOs are ready to be launched starting June. Priyanka Gawande joined us with details.

Any cess imposed on sugar will reduce prices: Sakthi Sugars

Any cess imposed on sugar will reduce prices: Sakthi Sugars

Apr 24 2018

M Manickam, MD at Sakthi Sugars says they are waiting for decision, relief package provided to sugar cos post GoM meet.

Steady Q4 for Bharat Financial

Steady Q4 for Bharat Financial

Apr 24 2018

MR Rao, CEO & MD at Bharat Financial says the company expects 40-50% growth in terms of loan book; expects PAT at Rs 620 Cr.

NCLT allows Liberty House bid

NCLT allows Liberty House bid

Apr 23 2018

NCLT has allowed consideration of Liberty House's bid for Bhushan Power & Steel. Ashutosh Kumar reports.

CoC rejects all 3 bids for Orchid Pharma

CoC rejects all 3 bids for Orchid Pharma

Apr 23 2018

Orchid Pharma is in RBI's second list of defaulters and is at NCLT currently. The latest update is that the CoC has recently rejected all the three bids for Orchid Pharma. Priyanka Gawande reports.

Plan to invest Rs 2,500 Cr over next 4 years: Nalco

Plan to invest Rs 2,500 Cr over next 4 years: Nalco

Apr 19 2018

TK Chand, CMD at Nalco says the company’s profit has risen by nearly Rs 85-100 Cr on rise of aluminium price by $100/Tn.

Fin Min: RBI to decide on Feb 12 circular

Fin Min: RBI to decide on Feb 12 circular

Apr 19 2018

The Finance Ministry reiterated on the February 12 circular, that it raised the concerns of banks and other stakeholders with the central bank on the new norms, effectively lobbing the matter back to the RBI. Meghna Mittal joined us with details.

Targeting 15-20% growth in FY19: Royal Orchid

Targeting 15-20% growth in FY19: Royal Orchid

Apr 18 2018

Amit Jaiswal, CFO at Royal Orchid Hotels says that hotels have not seen surge in room rates but expect average room rates to go up going ahead once the occupancy rates cross 70%.

Indian Markets

 
  • SENSEX

    34,501.27 115.37   (-0.33 %)
  • NIFTY

    10,570.55 43.80   (-0.41 %)
sensex-box-shadowimg

Global Markets

 

Stocks In News

 

ZENSAR TECH Q4

Revenue up 9.5% at Rs 814 Cr vs Rs 743 Cr

EBIT up 79% at Rs 82 Cr vs Rs 45.8 Cr

EBIT margin at 10% vs 6.1%

Net Profit up 6.9x at Rs 74 Cr vs Rs 10.7 Cr

Other Income at Rs 26.7 Cr vs Loss of Rs 22.8 Cr

All figures are consolidated and comparable QoQ

PERSISTENT TECH Q4

Net Sales up 19% at Rs 344 Cr vs Rs 289 Cr

EBITDA up 15.7% at Rs 191 Cr vs Rs 165 Cr

EBTDA Margin at 55.5% vs 57%

Net Profit up 40.5% at Rs 142 Cr vs Rs 101 Cr

All figures are Consolidated & comparable YoY

OBEROI REALTY Q4

Net Sales up 19% at Rs 344 Cr vs Rs 289 Cr

EBITDA up 15.7% at Rs 191 Cr vs Rs 165 Cr

EBTDA Margin at 55.5% vs 57%

Net Profit up 40.5% at Rs 142 Cr vs Rs 101 Cr

All figures are Consolidated & comparable YoY

GIC HSG FINANCE Q4

PAT At Rs 60 Cr vs Rs 46.6 Cr, Up 28.8% YoY

NII at Rs 109 cr vs Rs 100 cr, up 9%

Revenue From Ops At Rs 296 Cr Vs Rs 266 Cr, Up 11.3% YoY

IDFC BANK Q4

PAT Rs 41.9 Cr vs Rs 176 Cr, Down 76% YoY

NII At Rs 453 Cr vs Rs 502 Cr, Down 10% YoY

Gross NPA At 3.31% vs 5.62% QoQ;

Net NPA At 1.69% vs 2.52% QoQ

Provisions At Rs 242 Cr vs Rs 108.6 Cr , up 2.2x QoQ

RAYMOND Q4

Revenue Rs 1,655 Cr vs Rs 1,506 Cr, Up 10% YoY

EBITDA Rs 176 Cr vs Rs 145 Cr, Up 21% YoY

EBITDA Margin 10.6% vs 9.6% YoY

PAT Rs 53 Cr vs Rs 33 Cr, Up 60% YoY

All Figures Are Consolidated

twitter @BTVI